◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Vestibular Schwannoma
Sponsor Christoph Arnoldner
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age 18 Years
Max Age 99 Years
Start Date 2017-05-23
Completion 2026-05-23
All Conditions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation are included. The goal of the study is to correlate the eABR results with postoperative hearing results.
Eligibility Criteria
Inclusion Criteria: * Patients between 18 and 99 years undergoing translabyrinthine vestibular schwannoma resection * Patients wanted hearing rehabilitation with a cochlear implant Exclusion Criteria: * patients who do not want to be part of the study
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology